(3R,4R)-(3-HYDROXY-PIPERIDIN-4-YL)-CARBAMIC ACID TERT-BUTYL ESTER, 95.0%, 10g

1-Ethylpiperidine>98.0%(GC)(T)25mL

2-Amino-9-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3H-purine-6,8(7H,9H)-dione, 95.0%, 250mg

Di-?-chlorobis[2'-(amino-N)[1,1'-biphenyl]-2-yl-C]dipalladium(II), 98%, 5g

2-Hydroxy-4,6-dimethyl-5-nitronicotinonitrile, 95.0%, 1g

1-[4-(Aminomethyl)piperidin-1-yl]ethanone hydrochloride, 95.0%, 5g

3H-IMIDAZO[4,5-C]PYRIDINE-7-CARBONITRILE, 95.0%, 1g

(R)-2-((tert-Butoxycarbonyl)amino)-2-(thiophen-3-yl)acetic acid, 95.0%, 500mg

Ethyl 3-(4-Bromophenyl)-1H-pyrazole-5-carboxylate, 95.0%, 250mg

3,5-Dibromo-4-(trifluoromethyl)pyridin-2-amine, 95.0%, 500mg

Matraces de fondo plano ROTILABO® con junta esmerilada, 1000 ml, 45/40, 1 Pieza

4-((4-BUTYL-2,6-DIFLUOROPHENYL)ETHYNYL)-4'-PROPYL-1,1'-BIPHENYL, 95%, 5g

3-Hydroxythiobenzamide, 98.0%, 1g